What is Animalcare Group Plc?
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR · Verdict
Moderate reward · low risk
ANCR stands out on cash flow and volatility, but watch the growth signal.
Based on 88% data coverage
ANCR · Verdict
16% free-cash-flow margin
Top decile vs peers
Interest covered 12.6×
Revenue +0.1% CAGR
P/E 24.0×
Model-based scoring. For information only — not financial advice.
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 229.23M, and a P/E ratio of 83.0x.
The scoring profile indicates limited reward potential at this time, with profitability and momentum offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.